Uncategorized
Takeda leads wave of orexin drugs with potential to upend narcolepsy market
Takeda leads wave of orexin drugs with potential to upend narcolepsy market
The FDA’s August approval of Takeda’s Orzeyful for treating the full set of narcolepsy symptoms initiated a new era in the sleep market. Read More